Embolization of the ASD closure device is a rare but potentially fatal complication of percutaneous atrial septal defect (ASD) closure. We report a case of 22-year-old man who underwent ASD device closure with 32 mm Amplatzer device, which was embolized to the pulmonary artery without symptom one day after successful device implantation.

Percutaneous patent foramen ovale (PFO) closure is mainly performed for secondary prevention of presumed paradoxical embolism. Since a residual shunt has been associated with recurrent events, complete PFO closure is desirable. We report the first case of ultimately successful percutaneous PFO closure using successively 3 Amplatzer PFO devices.

Abstract Introduction Atrial septal defects are the second most frequent congenital heart diseases and their treatment of choice is percutaneous approach. Complications associated infrequent mainly related with puncture. Other complications such as embolism or endocarditis uncommon. Clinical case A 17-year-old woman whose only medical history interest was an ostium secundum-type atrial defect t...

AIM To evaluate the safety and efficacy of transcatheter closure of secundum atrial septal defects (ASD) with the Amplatzer septal occluder. METHODS 236 consecutive patients with a significant ASD (age 6 months to 46 years, median 5 years; body weight 6.5-79 kg, median 18 kg) were considered for transcatheter closure with the Amplatzer septal occluder; 18 patients with defects that were too l...

Background: Despite technical improvements over the years, interventional closure of persistent ductus arteriosus in infants remains a challenge. Objectives: To assess safety, efficacy, and follow up results of closure of symptomatic persistent ductus arteriosus in infants using the self-expanding and repositionable Amplatzer device. Setting: Queen Alia Heart Institute (QAHI), a tertiary cardia...

Persistent patency of the arterial duct represents one of the most common lesions in the field of congenital cardiac disease. The strategies for management continue to evolve. In this review, we focus on management beyond the neonatal period. We review the temporal evolution of strategies for management, illustrate the currently available the techniques for permanent closure of the patent arter...